As adrenal neuroblastoma shows a much higher incidence of MYCN amplification and segmental genomic aberrations [12,13,14], it should be noted that the BET pathways include effects on genomic stability. The gene discussed is MYCN; the disease is adrenal gland neuroblastoma.